India restricts specific cold medicines for children under four. Investors should monitor compliance costs and portfolio ...
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) has released topline results from the Phase 3 LUCIDITY trial of avexitide on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results